FAM86EP: A Potential Drug Target and Biomarker for Family with Sequence Similarity 86

Target Name: FAM86EP

NCBI ID: G348926

FAM86EP

Other Name(s): family with sequence similarity 86 member E, pseudogene | Family with sequence similarity 86, member E, pseudogene

FAM86EP: A Potential Drug Target and Biomarker for Family with Sequence Similarity 86

FAM86 is a protein that plays a crucial role in various cellular processes, including cell adhesion, migration, and invasion. It is a member of the E-cadherin gene family, which is known for its role in the development and maintenance of tissues and organs. The FAM86 gene has been implicated in the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Recent studies have identified a pseudogene named FAM86EP in some individuals from the African population. This pseudogene has a high degree of sequence similarity to the coding gene, but is not functional. FAM86EP has also been shown to be expressed in various tissues and organs, including brain, heart, and pancreas.

The Potential Role of FAM86EP as a Drug Target

Drug resistance is a major challenge in the treatment of many diseases. The FAM86EP pseudogene has been identified as a potential drug target due to its involvement in various cellular processes that are related to disease progression.

FAM86EP has been shown to be involved in the regulation of cell adhesion, which is a critical process in the development and maintenance of tissues and organs. It is a known regulator of the cadherin complex, which is a protein that plays a central role in cell-cell adhesion. The cadherin complex is also involved in the development of various diseases, including cancer.

FAM86EP has also been shown to be involved in the regulation of cell migration and invasion. These processes are critical for the development and progression of many diseases, including cancer.

FAM86EP may also be a potential biomarker for some diseases. The identification of individuals with the FAM86EP pseudogene has been shown to be associated with an increased risk of certain diseases, including cancer. This suggests that FAM86EP may be a useful biomarker for the diagnosis and prognosis of these diseases.

The Potential for Personalized Medicine

The identification of the FAM86EP pseudogene has also implications for personalized medicine. By targeting individuals with the FAM86EP pseudogene, researchers may be able to develop more effective therapies for the treatment of diseases that are associated with this pseudogene.

Conclusion

FAM86EP is a pseudogene that has a high degree of sequence similarity to the coding gene for the protein FAM86. It has also been shown to be involved in various cellular processes that are related to disease progression. The identification of FAM86EP as a potential drug target and biomarker has implications for the development of more effective therapies for various diseases. Further research is needed to fully understand the role of FAM86EP in diseases and to develop more effective treatments.

Protein Name: Family With Sequence Similarity 86 Member E, Pseudogene

The "FAM86EP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM86EP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets